Genetic testing is cost-effective, beneficial for newly diagnosed patients with metastatic GIST

on
Because gastrointestinal stromal tumors (GIST) are sensitive to the targeted small molecule therapy imatinib, oncologists tend to treat all patients with metastatic GIST with this drug. However, because this rare type of cancer is caused by different genetic mutations, imatinib does not help all patients equally.

from The Medical News https://ift.tt/3cC3hAC

Comments

Post a Comment

diet weight loss

diet weight loss

diet weight loss

Legal Notice: Product prices and availability are subject to change. Visit corresponding website for more details. Trade marks & images are copyrighted by their respective owners.

helth

health

health

Legal Notice: Product prices and availability are subject to change. Visit corresponding website for more details. Trade marks & images are copyrighted by their respective owners.